Docetaxel induced nail toxicity

NewsBot · Aug 8, 2018

Members do not see these Ads. Sign Up.
Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results
Chabanol H et al
Bull Cancer. 2018 Aug 2.

BACKGROUND:
Docetaxel is frequently used for the treatment of metastatic prostate cancer patients. Nail toxicity is a commonly described side effect, but no precise recommendation exists concerning its management. We experimented the integration of a podiatrist in routine cancer care.

METHODS:
Patients having received docetaxel for a metastatic prostate cancer since the arrival of the podiatrist were studied.

RESULTS:
Fifty-six patients were included, half had docetaxel-induced nail toxicity and 18 were referred to the podiatrist. The integration of the podiatrist in routine care was feasible and allowed characterizing nail toxicity. The main lesions observed were non-coagulated nail hematomas, coagulated nail hematomas and onycholysis. This experience led to propose an integrated care for docetaxel-induced nail toxicity.

CONCLUSION:
The integration of podiatrist care is feasible in routine cancer care and can help improving the management of docetaxel-induced nail toxicity in metastatic prostate cancer patients.
Click to expand...

NewsBot The Admin that posts the news.

Diagnosis of Exercise Induced Leg Pain

Sitagliptin-induced Achilles enthesopathy

Gold-Induced Cytokine (GOLDIC®) Injection Therapy in Patient with Plantar Fasciitis

Talar beak-induced intermittent ischemia of the foot

Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments

Isotretinoin induced achilles tendinopathy

Detection of alcohol induced gait changes

Share This Page